The main outcomes were the proportion of patients with plasma HIV-1 RNA less than 50 copies per mL at week 48 as defined by the the US Food and Drug Adminstration ( FDA ) snapshot algorithm ( pre-specified non-inferiority margin of 12 % ) and pre-specified renal and bone endpoints at 48 weeks .